van 't Veer L - Search Results

1

Expression profiling of circulating tumor cells in metastatic breast cancer.

Lang JE, Scott JH, Wolf DM, Novak P, Punj V, Magbanua MJ, Zhu W, Mineyev N, Haqq CM, Crothers JR, Esserman LJ, Tripathy D, van 't Veer L, Park JW. Lang JE, et al. Breast Cancer Res Treat. 2015 Jan;149(1):121-31. doi: 10.1007/s10549-014-3215-0. Epub 2014 Nov 29. Breast Cancer Res Treat. 2015. PMID: 25432738 Free PMC article. Clinical Trial.

2

Comparison of immunocytochemistry, reverse transcriptase polymerase chain reaction, and nucleic acid sequence-based amplification for the detection of circulating breast cancer cells.

Lambrechts AC, Bosma AJ, Klaver SG, Top B, Perebolte L, van' t Veer LJ, Rodenhuis S. Lambrechts AC, et al. Breast Cancer Res Treat. 1999 Aug;56(3):219-31. doi: 10.1023/a:1006261731125. Breast Cancer Res Treat. 1999. PMID: 10573113

3

Detection of circulating breast tumor cells by differential expression of marker genes.

Bosma AJ, Weigelt B, Lambrechts AC, Verhagen OJ, Pruntel R, Hart AA, Rodenhuis S, van 't Veer LJ. Bosma AJ, et al. Clin Cancer Res. 2002 Jun;8(6):1871-7. Clin Cancer Res. 2002. PMID: 12060630

4

Expression profiling predicts outcome in breast cancer.

van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Bernards R, Friend SH. van 't Veer LJ, et al. Breast Cancer Res. 2003;5(1):57-8. doi: 10.1186/bcr562. Epub 2002 Dec 4. Breast Cancer Res. 2003. PMID: 12559048 Free PMC article. No abstract available.

5

Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients.

Weigelt B, Bosma AJ, Hart AA, Rodenhuis S, van 't Veer LJ. Weigelt B, et al. Br J Cancer. 2003 Apr 7;88(7):1091-4. doi: 10.1038/sj.bjc.6600868. Br J Cancer. 2003. PMID: 12671691 Free PMC article.

6

Insulin-like growth factor (IGF)-system mRNA quantities in normal and tumor breast tissue of women with sporadic and familial breast cancer risk.

Voskuil DW, Bosma A, Vrieling A, Rookus MA, van 't Veer LJ. Voskuil DW, et al. Breast Cancer Res Treat. 2004 Apr;84(3):225-33. doi: 10.1023/B:BREA.0000019954.59130.d3. Breast Cancer Res Treat. 2004. PMID: 15026620

7

Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer.

Weigelt B, Hu Z, He X, Livasy C, Carey LA, Ewend MG, Glas AM, Perou CM, Van't Veer LJ. Weigelt B, et al. Cancer Res. 2005 Oct 15;65(20):9155-8. doi: 10.1158/0008-5472.CAN-05-2553. Cancer Res. 2005. PMID: 16230372

8

Towards an optimized platform for the detection, enrichment, and semi-quantitation circulating tumor cells.

Molloy TJ, Bosma AJ, van't Veer LJ. Molloy TJ, et al. Breast Cancer Res Treat. 2008 Nov;112(2):297-307. doi: 10.1007/s10549-007-9872-5. Epub 2008 Jan 23. Breast Cancer Res Treat. 2008. PMID: 18213476

9

Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen.

Kok M, Linn SC, Van Laar RK, Jansen MP, van den Berg TM, Delahaye LJ, Glas AM, Peterse JL, Hauptmann M, Foekens JA, Klijn JG, Wessels LF, Van't Veer LJ, Berns EM. Kok M, et al. Breast Cancer Res Treat. 2009 Jan;113(2):275-83. doi: 10.1007/s10549-008-9939-y. Epub 2008 Mar 4. Breast Cancer Res Treat. 2009. PMID: 18311582

10

The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1-3 positive lymph nodes in an independent validation study.

Mook S, Schmidt MK, Viale G, Pruneri G, Eekhout I, Floore A, Glas AM, Bogaerts J, Cardoso F, Piccart-Gebhart MJ, Rutgers ET, Van't Veer LJ; TRANSBIG Consortium. Mook S, et al. Breast Cancer Res Treat. 2009 Jul;116(2):295-302. doi: 10.1007/s10549-008-0130-2. Epub 2008 Jul 27. Breast Cancer Res Treat. 2009. PMID: 18661261

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

455 results

Search Page

Filters